This inventor holds 2 USPTO granted patents. Top assignees: Kyowa Hakko Kogyo Co., Ltd., Mect Corporation. Active years: 1992-1993.
Company Filing History:
Years Active: 1992-1993
Title: Kuniko Hashigaki: Innovator in Quinoline Compounds
Introduction
Kuniko Hashigaki is a prominent inventor based in Okayama, Japan. She has made significant contributions to the field of chemistry, particularly in the development of novel compounds with potential therapeutic applications. With a total of 2 patents, her work has garnered attention in both academic and industrial circles.
Latest Patents
Hashigaki's latest patents include innovative compounds that show promise in medical applications. One of her notable inventions is the "Condensed quinoline system N-glycosides." This invention provides condensed quinoline compounds represented by a specific general formula, which are effective for inhibiting KB-cell growth and prolonging the lifespan of mice implanted with tumor P-388. Another significant patent is for "Arylalkylamine derivatives," which discloses a novel arylalkylamine derivative represented by a specific formula, where X can be --O--, --CH2--, or --NR3--, with R3 representing hydrogen or lower alkyl.
Career Highlights
Throughout her career, Kuniko Hashigaki has worked with notable companies such as Mect Corporation and Kyowa Hakko Kogyo Co., Ltd. Her experience in these organizations has allowed her to refine her skills and contribute to groundbreaking research in her field.
Collaborations
Hashigaki has collaborated with esteemed colleagues, including Masatoshi Yamato and Haruhiko Manabe. These partnerships have facilitated the exchange of ideas and fostered innovation in her research endeavors.
Conclusion
Kuniko Hashigaki's contributions to the field of chemistry through her patents and collaborations highlight her role as a significant innovator. Her work continues to inspire advancements in therapeutic compounds and showcases the impact of dedicated research in improving health outcomes.